Summary
In this short article for an Australian nursing magazine, New Zealand mental health nurse Jason Watson challenges the idea that withholding gender-affirming treatment from young people drives them to suicide. He looks at six large, long-term studies from the Netherlands, Sweden, Denmark, the UK and Finland. In his reading, suicide rates among transgender people stayed well above the general population after treatment, rates fell over time only for trans women in one Dutch study, and the Tavistock clinic review found no rise in youth suicides after access to puberty blockers was restricted in England. He concludes that the 'transition or suicide' claim is weak at best. The article was printed in July 2026, then removed from the journal's website after complaints; the nurses' union apologised for publishing it but later said this did not imply misconduct by the author. It is an opinion piece, not a systematic review: it picks a handful of studies, most of them about adults, and some of its readings go further than the studies' own authors. For example, the Finnish study it relies on most concluded that suicide risk was explained by mental illness and that gender reassignment did not change suicide risk either way.
Key findings
- Watson pune la îndoială afirmația repetată pe scară largă că tinerii cărora li se refuză tratamentul de afirmare a genului au un risc mai mare de suicid, afirmație susținută de WPATH și de oficiali ai sănătății din SUA.
- El analizează șase studii de urmărire pe termen lung din Țările de Jos, Suedia, Danemarca, Marea Britanie și Finlanda, cu între 324 și peste 15.000 de persoane și cu perioade de urmărire de la 5 la 46 de ani.
- El raportează că ratele de suicid și de deces în rândul persoanelor transgen au rămas mai mari decât în populația generală după tratament și că doar un studiu olandez a constatat o scădere a suicidului în timp, în cazul femeilor trans.
- El subliniază analiza suicidurilor de la clinica Tavistock din Anglia, care a identificat 12 suicide și nicio creștere a suicidurilor în rândul tinerilor după restricționarea blocantelor pubertare, în ciuda previziunilor privind o creștere bruscă.
- El concluzionează că narațiunea „tranziție sau suicid” este „cel puțin fragilă și, în cel mai rău caz, pur și simplu incorectă”, în acord cu concluzia Raportului Cass că cea mai mare parte a cercetării din acest domeniu are o calitate slabă.
- Sindicatul asistenților medicali din Australia a retras articolul de pe site-ul revistei sale în iulie 2026 și și-a cerut scuze pentru publicarea lui, precizând ulterior că aceasta nu a reprezentat o constatare de abatere din partea autorului.
Abstract
This short article examines the narrative that trans youth who are not provided with gender-affirming healthcare face an increased risk of suicide, a view stated by WPATH's Standards of Care 8 and the US Assistant Secretary for Health in 2022. Noting the Cass Review's finding that research in this field is of poor quality, the author summarises six long-term follow-up studies from the Netherlands (Wiepjes 2020; de Blok 2021), Sweden (Dhejne 2011), Denmark (Erlangsen 2023), England (Appleby 2024, a review of suicides among Tavistock gender clinic patients) and Finland (Ruuska 2024), with sample sizes from 324 to 15,032 and follow-up from five to 46 years, and describes what each reported about suicide and mortality.
Conclusion
Only one finding, the decline in suicide among trans women over time in Wiepjes (2020), appeared to support the narrative that lack of access to gender-affirming care increases suicide risk. The author argues the other studies showed no evidence that treatment reduced suicidal behaviour, and reported higher 'other' mortality after treatment, and that Ruuska (2024), the only study with a matched control group, found much higher suicide and overall mortality among trans people. He concludes the 'trans suicide narrative' is 'at least tenuous and at most simply incorrect', consistent with the Cass Review's view that most research in this field is of poor quality.